2016•Unpublished venueRequires access

Biomarkers in hepatitis B virus-related liver failure

Yuan Xue, Chunyan Ye

Abstract

Hepatitis B virus (HBV)-related liver failure is an end-stage liver disease with a high mortality. Biomarkers, which are of interest, are helpful for diagnosis and treatment of liver failure. The purpose of this review is to highlight the recent advances in this field. Although many new biomarkers can improve the prognostic efficacy, the dynamic biochemical function of liver and kidney as well as the function of coagulation are still the most practical and common indexes for the development and prognosis evaluation of liver failure. Key words: Hepatitis B/CO/ME; Liver failure/CO/ME; Review

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Hepatitis B virus, Liver failure, Liver disease, Liver function, Hepatitis a virus, Hepatitis B, Disease